These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2746999)

  • 1. [Studies on kallikrein activity in diabetic patient with hypertension caused by nephropathy].
    Kunii N
    Nihon Jinzo Gakkai Shi; 1989 Jan; 31(1):39-48. PubMed ID: 2746999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regulation of natriuresis in diabetic nephropathy].
    Późniak J
    Ann Acad Med Stetin; 2000; 46():241-52. PubMed ID: 11712308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reduction of urinary kallikrein in hypertensive diabetics].
    Marre M; Alhenc-Gélas F; Ménard J; Passa P
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):831-4. PubMed ID: 3099698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ontogenic study of renal tissue kallikrein in Okamoto spontaneously hypertensive rats: comparisons with human hypertensive nephropathy.
    Figueroa CD; Bhoola KD; MacIver AG; Mackenzie JC
    Nephrol Dial Transplant; 1992; 7(6):516-25. PubMed ID: 1320231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal kallikrein in diabetic nephropathy].
    Pérez Blanco FJ; Cuesta López MJ; Fernández García C; Saucedo Sánchez R; Rodríguez Cuartero A
    Rev Clin Esp; 1991 Feb; 188(3):123-6. PubMed ID: 1780509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of aprotinin, a glandular kallikrein inhibitor, on renin release and urinary sodium excretion in mild essential hypertensives.
    Madeddu P; Oppes M; Soro A; Dessi'-Fulgheri P; Glorioso N; Manunta F; Rubatti S; Rappelli A
    Agents Actions Suppl; 1987; 22():373-80. PubMed ID: 2449054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium depletion on urinary excretion of active and inactive kallikrein in glomerulonephritic patients.
    Tsai TJ; Chen YM; Yeah FT; Hsieh BS; Chen WY; Yen TS
    J Formos Med Assoc; 1991 Jan; 90(1):105-8. PubMed ID: 1679103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal kallikrein in diabetic patients with hypertension accompanied by nephropathy.
    Baba T; Murabayashi S; Ishizaki T; Ido Y; Aoyagi K; Takebe K
    Diabetologia; 1986 Mar; 29(3):162-7. PubMed ID: 3516773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats.
    Johnston CI; Matthews PG; Dax E
    Clin Sci Mol Med Suppl; 1976 Dec; 3():283s-286s. PubMed ID: 1071628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus].
    Sánchez-Hueso MC; Mateo-Caãs J; Zamora-Madaria E
    An Med Interna; 1995 May; 12(5):216-20. PubMed ID: 7669872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of alterations in sodium and water metabolism on urinary excretion of active and inactive kallikrein in man.
    Lieberthal W; Oza NB; Arbeit L; Bernard DB; Levinsky NG
    J Clin Endocrinol Metab; 1983 Mar; 56(3):513-9. PubMed ID: 6549759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary kallikrein in hypertensive animal models.
    Keiser HR; Geller RG; Margolius HS; Pisano JJ
    Fed Proc; 1976 Feb; 35(2):199-202. PubMed ID: 1248654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal kallikrein: a risk marker for nephropathy in children with sickle cell disease.
    Bergmann S; Zheng D; Barredo J; Abboud MR; Jaffa AA
    J Pediatr Hematol Oncol; 2006 Mar; 28(3):147-53. PubMed ID: 16679937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal kallikrein: variations in relation to sodium intake and experimental renovascular hypertension (author's transl)].
    Baudin G; Wahba WK; Casellas D; Mimran A
    Ann Biol Clin (Paris); 1979; 37(1):7-10. PubMed ID: 443614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships among urinary kallikrein, mineralocorticoids and human hypertensive disease.
    Margolius HS; Horwitz D; Pisano JJ; Keiser HR
    Fed Proc; 1976 Feb; 35(2):203-6. PubMed ID: 1248655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal kallikrein and PGE in the exaggerated fractional Na excretion in patients with chronic renal failure.
    Abe K; Haruyama T; Sato M; Imai Y; Yasujima M; Seino M; Chiba S; Hiwatari M; Kasai Y; Tajima J; Itoh S; Yoshinaga K
    Adv Exp Med Biol; 1983; 156 (Pt B)():977-84. PubMed ID: 6344585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary kallikrein excretion in insulin-dependent diabetes mellitus and its relationship to glycemic control.
    Mayfield RK; Margolius HS; Levine JH; Wohltmann HJ; Loadholt CB; Colwell JA
    J Clin Endocrinol Metab; 1984 Aug; 59(2):278-86. PubMed ID: 6564131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study on inactive renin in the plasma of patients with diabetes mellitus].
    Yoshida H
    Hokkaido Igaku Zasshi; 1989 May; 64(3):232-42. PubMed ID: 2670725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced ratio of active-to-total urinary kallikrein in essential hypertension.
    Lieberthal W; Arbeit L; Oza NB; Bernard DB; Levinsky NG
    Hypertension; 1983; 5(4):603-9. PubMed ID: 6345366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.